Friday, June 14, 2019 3:02:40 PM
(I corrected their spelling)
https://www.wvnews.com/wvumedicine/wvu-orthopaedic-surgeons-offer-cartilage-repair-procedure/article_cca3e436-8e0a-11e9-af37-5b1581bf59ef.html
MORGANTOWN — Orthopedic surgeons at WVU Medicine are now offering a procedure for the treatment of full thickness cartilage defects of the knee.
Matrix-impregnated autologous chondrocyte implantation, known as MACI, provides surgeons with a technically improved way to rebuild damaged and missing cartilage. WVU Medicine J.W. Ruby Memorial Hospital is the only hospital in the state to offer this procedure.
“With this procedure, we are able to repair defects to the cartilage of the knee before they progress and develop into osteoarthritis, which is more difficult to treat,” said Barry McDonough, M.D., WVU Medicine orthopedic surgeon.
In the two-stage procedure, surgeons perform a biopsy of healthy cartilage tissue from a non-weight bearing area of the knee to be sent to the Vericel lab, where chondrocytes, the building blocks of cartilage, are extracted and grown on a collagen matrix.
The prepared matrix is then sent to the surgeon, who implants it into the knee to completely fill the defect.
“In the past, procedures to repair damaged cartilage were lengthy and technically difficult,” McDonough said. “Surgeons were required to stitch a matrix in place and inject the cartilage-forming chondrocytes under it, which was time-consuming. This procedure, however, uses improved tools that simplify the process and eliminate the need for stitches to hold the implant in place.”
This procedure is appropriate for patients ages 18 to 55 who have cartilage defects due to trauma and is not available as a treatment for arthritic knee pain.
Patients can expect to return to full weight bearing six-to-eight weeks after the procedure and may require a recovery period of nine months or longer before returning to high-impact athletic activity.
Recent VCEL News
- Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024 • GlobeNewswire Inc. • 10/24/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/21/2024 08:05:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 08:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 08:05:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/17/2024 08:27:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 08:43:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 08:31:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:06:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/02/2024 08:54:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:06:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 05:16:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:05:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 08:10:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 08:05:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 08:16:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 08:55:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:06:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:05:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/04/2024 02:25:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 05:27:28 PM
- Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 • GlobeNewswire Inc. • 08/29/2024 01:17:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 12:03:45 PM
- Vericel Announces FDA Approval and Commercial Availability of MACI Arthro • GlobeNewswire Inc. • 08/26/2024 11:45:47 AM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 08/16/2024 08:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:05:17 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM